蓝丰生化: 关于持股5%以上股东减持股份触及1%整数倍的公告

Core Viewpoint - Jiangsu Lanfeng Biological Chemical Co., Ltd. announced that its major shareholder, Hainan Wenqin Private Fund Management Partnership, plans to reduce its holdings by up to 9,795,589 shares, representing 2.61% of the total share capital [1] Group 1: Shareholder Reduction Details - On September 4, 2025, Hainan Wenqin reduced its holdings by 7,496,000 shares, which is 2.00% of the total share capital, bringing its total holdings down from 33,589,000 shares to 26,093,000 shares, reducing its ownership percentage from 8.95% to 6.95% [2] - The reduction was executed through block trading, and the shares sold were part of a previously disclosed plan [2][3] Group 2: Compliance and Impact - The company confirmed that the reduction does not violate any laws or regulations and does not harm the interests of the company or minority shareholders [3] - The company stated that the reduction will not affect its ongoing operations or control [3]